Key facts
- This page summarizes Philippe Busque's Form 4 filing for Cytek Biosciences, Inc. (CTKB).
- 9 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 20 Nov 2025, 19:07.
Philippe Busque - 18 Nov 2025 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)
- Reporting relationship
- SVP, GLOBAL SALES AND SERVICES
- Issuer ticker
- CTKB
- Reported as of
- 18 Nov 2025
- Net transaction value
- -$10,424
- SEC form
- 4
- Accepted by SEC
- 20 Nov 2025, 19:07:37 UTC
- Prior SEC filing
- 20 Aug 2025
- Next SEC filing
- 12 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Valerie Barnett, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Philippe Busque filed Form 4 for Cytek Biosciences, Inc. (CTKB) on 20 Nov 2025.
Change
- Previous filing in this sequence was filed on 20 Aug 2025.
- Current net transaction value: -$10,424.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001991396
Primary reporting owner
Busque Philippe
- Relationship
- SVP, GLOBAL SALES AND SERVICES
- Address
- C/O CYTEK BIOSCIENCES, INC., 47215 LAKEVIEW BLVD., FREMONT
- Signature
- /s/ Valerie Barnett, Attorney-in-Fact
- Signature date
- 20 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CTKB
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,536
- Change %
- +6.6%
- Price
- Shares after
- 24,952
- Date
- 18 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
CTKB
transaction
Common Stock
Tax liability
- Transaction value
- $2,173
- Shares
- -393
- Change %
- -1.6%
- Price
- $5.53
- Shares after
- 24,559
- Date
- 18 Nov 2025
- Ownership
- Direct
- Footnotes
- F2
CTKB
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +2,210
- Change %
- +9%
- Price
- Shares after
- 26,769
- Date
- 18 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
CTKB
transaction
Common Stock
Tax liability
- Transaction value
- $3,124
- Shares
- -565
- Change %
- -2.1%
- Price
- $5.53
- Shares after
- 26,204
- Date
- 18 Nov 2025
- Ownership
- Direct
- Footnotes
- F2
CTKB
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +3,625
- Change %
- +14%
- Price
- Shares after
- 29,829
- Date
- 18 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
CTKB
transaction
Common Stock
Tax liability
- Transaction value
- $5,126
- Shares
- -927
- Change %
- -3.1%
- Price
- $5.53
- Shares after
- 28,902
- Date
- 18 Nov 2025
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CTKB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,536
- Change %
- -15%
- Price
- $0.000000
- Shares after
- 8,714
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,536
- Exercise price
- Footnotes
- F1, F3
CTKB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -2,210
- Change %
- -9.7%
- Price
- $0.000000
- Shares after
- 20,628
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,210
- Exercise price
- Footnotes
- F1, F4
CTKB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -3,625
- Change %
- -7%
- Price
- $0.000000
- Shares after
- 48,338
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,625
- Exercise price
- Footnotes
- F1, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
Footnote F2
Represents the number of shares withheld by and surrendered to the Issuer on November 18, 2025, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
Footnote F3
The shares subject to the RSU Award shall vest over four years with 13/48 of the total shares underlying the RSU Award vesting on May 18, 2024; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; 4/48 of the total shares underlying the RSU Award vesting on March 10, 2025 and each March 10 thereafter; and 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter.
Footnote F4
The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2024 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2025 and each March 10 thereafter.
Footnote F5
The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter, until fully vested.